MIR503HG could bind to the transcription factor SPI1 to prevent SPI1 from binding to the TMEFF1 promoter region, thereby suppressing the tumorigenicity of ovarian cancer cells. The gene discussed is SPI1; the disease is ovarian carcinoma.